PedAM
Pediatric Disease Annotations & Medicines
| Disease | relapsing-remitting multiple sclerosis |
| Phenotype | C0023524|progressive multifocal leukoencephalopathy |
| Sentences | 1 |
| PubMedID- 20442571 | Recent findings: natalizumab, a mab targeting the alpha-4 integrins, which is efficient in relapsing-remitting multiple sclerosis, has been associated with progressive multifocal leukoencephalopathy (pml). |
Page: 1